Subsidiary HK Inno.N decides to invest 97 billion won in solid dosage form production facility expansion

Subsidiary HK Inno.N decided to invest 97 billion won to newly expand solid dosage form production facilities with total floor area of 12,561.98㎡ within Osong plant
Investment period from May 21, 2026 to January 31, 2028, representing 7.3% of equity (1.33 trillion won)
Purpose is to secure mid- to long-term growth drivers and strengthen competitiveness
Investment amount and period may change depending on construction progress

ADVERTISEMENT (250px+)